Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: a new algorithm for patient selection and personalized treatment

od Buttitta, Fiamma, Felicioni, Lara, Lorito, Alessia Di, Cortellini, Alessio, Irtelli, Luciana, Brocco, Davide, Marino, Pietro Di, Traisci, Donatella, D’Ostilio, Nicola, Paolo, Alessandra Di, Malorgio, Francesco, Assalone, Pasquale, Felice, Sonia Di, Fabbri, Francesca, Cianci, Giovanni, Tursi, Michele De, Marchetti, Antonio
Wydane w Oncotarget (2020)